Holocene Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.7M Buy
628,000
+55,533
+10% +$6.5M 0.18% 150
2026
Q1
$68.9M Sell
572,467
-313,293
-35% -$36.2M 0.17% 149
2025
Q4
$93.2M Buy
885,760
+239,749
+37% +$22.5M 0.2% 137
2025
Q3
$54.2M Buy
+646,011
New +$53.2M 0.12% 164
2025
Q2
Sell
-149,521
Closed -$13.4M 838
2025
Q1
$13.4M Buy
+149,521
New +$14M 0.04% 268
2024
Q3
Sell
-2,486,403
Closed -$308M 807
2024
Q2
$308M Buy
2,486,403
+2,484,447
+127,017% +$320M 1.29% 11
2024
Q1
$258K Sell
1,956
-468,909
-100% -$57.8M ﹤0.01% 689
2023
Q4
$51.3M Buy
+470,865
New +$48.9M 0.2% 149
2022
Q4
Sell
-1,588,150
Closed -$137M 829
2022
Q3
$137M Sell
1,588,150
-561,898
-26% -$50.2M 0.87% 25
2022
Q2
$196M Buy
2,150,048
+299,087
+16% +$26.5M 1.18% 7
2022
Q1
$152M Buy
+1,850,961
New +$146M 0.79% 31
2020
Q1
Sell
-415,728
Closed -$36.1M 765
2019
Q4
$36.1M Buy
+415,728
New +$34.1M 0.32% 99
2018
Q2
Sell
-4,852
Closed -$252K 668
2018
Q1
$252K Sell
4,852
-6,769
-58% -$366K 0.01% 439
2017
Q4
$624K Buy
+11,621
New +$644K 0.02% 343

Other funds holding MRK

Holocene Advisors's MRK Position: Q2 2026 in Review

Holocene Advisors increased its Merck (MRK) stake by 9.7% in Q2 2026, buying an estimated $6.5M and bringing the position to 628,000 shares worth $80.7M. The position accounts for 0.18% of the portfolio, ranked #150.

Holocene Advisors first reported a position in MRK in Q4 2017 and has held it in 14 quarters since. The position peaked at $308M in Q2 2024. 3,849 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Holocene Advisors held 628,000 shares of Merck worth $80.7M as of Q2 2026.
  • Holocene Advisors bought 55,533 Merck shares in Q2 2026, an estimated $6.5M.
  • Merck made up 0.18% of Holocene Advisors's portfolio in Q2 2026, its #150 holding.
  • Holocene Advisors first reported a position in Merck in Q4 2017 and has held it in 14 quarters since.
  • Holocene Advisors's Merck position peaked at $308M in Q2 2024.
  • 3,849 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.